These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 12804984)

  • 41. Inhibition of dithranol inflammation by free-radical scavengers.
    Finnen MJ; Lawrence CM; Shuster S
    Lancet; 1984 Nov; 2(8412):1129-30. PubMed ID: 6150185
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A six month dermal irritation test with anthralins in the Göttingen miniature swine.
    Hanhijärvi H; Nevalainen T; Männistö P
    Arch Toxicol Suppl; 1985; 8():463-8. PubMed ID: 3913406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of methotrexate treatment on the expression of epidermal-fatty acid-binding protein (E-FABP) and apolipoproteins in patients with psoriasis.
    Owczarczyk-Saczonek A; Czerwiñska J; Orylska M; Placek W
    Postepy Dermatol Alergol; 2020 Jun; 37(3):401-406. PubMed ID: 32792883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. E-FABP: regulator of immune function.
    Zhang Y; Li B
    Oncoscience; 2014; 1(6):398-9. PubMed ID: 25594037
    [No Abstract]   [Full Text] [Related]  

  • 45. Liver fatty acid-binding protein might be a predictive marker of clinical response to systemic treatment in psoriasis.
    Baran A; Kiluk P; Maciaszek M; Świderska M; Flisiak I
    Arch Dermatol Res; 2019 Jul; 311(5):389-397. PubMed ID: 30993401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum Fatty Acid-Binding Protein 4 is Increased in Patients with Psoriasis.
    Baran A; Świderska M; Bacharewicz-Szczerbicka J; Myśliwiec H; Flisiak I
    Lipids; 2017 Jan; 52(1):51-60. PubMed ID: 27864793
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymorphisms in fatty acid binding protein 5 show association with type 2 diabetes.
    Bu L; Salto LM; De Leon KJ; De Leon M
    Diabetes Res Clin Pract; 2011 Apr; 92(1):82-91. PubMed ID: 21288588
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytoplasmic fatty acid-binding protein facilitates fatty acid utilization by skeletal muscle.
    Glatz JF; Schaap FG; Binas B; Bonen A; van der Vusse GJ; Luiken JJ
    Acta Physiol Scand; 2003 Aug; 178(4):367-71. PubMed ID: 12864741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transepidermal water vapour loss is not increased during and following dithranol irritation.
    Snater E; Janssen EA; van der Valk PG; van de Kerkhof PC
    Br J Dermatol; 1995 Jun; 132(6):908-12. PubMed ID: 7662568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Skin-derived antileukoproteinase (SKALP) and epidermal fatty acid-binding protein (E-FABP): two novel markers of the psoriatic phenotype that respond differentially to topical steroid.
    Kuijpers AL; Bergers M; Siegenthaler G; Zeeuwen PL; van de Kerkhof PC; Schalkwijk J
    Acta Derm Venereol; 1997 Jan; 77(1):14-9. PubMed ID: 9059669
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Implementation of fatty acid carriers to skin irritation and the epidermal barrier.
    Schürer NY
    Contact Dermatitis; 2002 Oct; 47(4):199-205. PubMed ID: 12492517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calcium-binding protein S100A7 and epidermal-type fatty acid-binding protein are associated in the cytosol of human keratinocytes.
    Hagens G; Masouyé I; Augsburger E; Hotz R; Saurat JH; Siegenthaler G
    Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):419-27. PubMed ID: 10191275
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Irritation and staining by dithranol (anthralin) and related compounds. III. Cumulative irritancy and staining during repeated chamber testing.
    Brandt H; Mustakallio KK
    Acta Derm Venereol; 1983; 63(3):237-40. PubMed ID: 6192640
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lack of upregulation of epidermal fatty acid binding protein in dithranol induced irritation.
    Kucharekova M; Vissers WH; Schalkwijk JJ; van de Kerkhof PC; van der Valk PG
    Eur J Dermatol; 2003; 13(3):254-7. PubMed ID: 12804984
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.